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Abstract
Background: An association between male subfertility and an increased risk of testicular cancer has been proposed, but
conflicting results of research on this topic have rendered this theory equivocal. To more precisely assess the association
between subfertility and the risk of testicular cancer, we performed a systematic review of international epidemiologic
evidence.
Principal Findings: We searched the Medline database for records from January 1966 to March 2008 complemented with
manual searches of the literature and then identified studies that met our inclusion criteria. Study design, sample size,
exposure to subfertility and risk estimates of testicular cancer incidence were abstracted. Summary relative risks (RRs) with
95% confidence intervals (CIs) were calculated using the DerSimonian and Laird model. All statistical tests were two-sided.
We identified seven case-control studies and two cohort studies published between 1987 and 2005. Analysis of the seven
case-control studies that included 4,954 participants revealed an overall statistically significant association between
subfertility and increased risk of testicular cancer (summary RR=1.68, 95% CI: 1.22 to 2.31), without heterogeneity between
studies (Q=8.46, P heterogeneity=0.21, I
2 statistics=0.29). The association between subfertility and testicular cancer was
somewhat stronger in the United States (summary RR=1.75, 95% CI: 1.01 to 3.02) than it was in Europe (summary RR=1.53,
95% CI: 1.22 to 1.92). The source of the control subjects had a statistically significant effect on the magnitude of the
association (population-based summary—RR=2.15, 95% CI: 1.11 to 4.17; hospital-based summary—RR=1.56, 95% CI: 0.93
to 2.61). After excluding possible cryptorchidism, an important confounding factor, we also found a positive association
between subfertility and increased risk of testicular cancer (summary RR=1.59, 95% CI: 1.28 to 1.98). These results were
consistent between studies conducted in the United States and in Europe (Q=0.20, P heterogeneity=0.66). Of the two
cohort studies that reported standardized incidence ratios, both reported a statistically significant positive association
between subfertility and increased risk of testicular cancer.
Conclusions: Our findings support a relationship between subfertility and increased risk of testicular cancer and apply to
the management of men with subfertility, and prevention and diagnosis of testicular cancer.
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Introduction
Testicular cancer is uncommon in most countries with an
incidence that ranges from ,1/100,000 to 10/100,000 and
accounts for ,1% of all cancers in men but ,60% of all cancers in
young males 15–35 years of age. Moreover, the incidence of
testicular cancer has doubled in the last 20–40 years [1,2]. The
most common type of testicular cancer is testicular germ cell
tumor (TGCT) and accounts for 95% of testicular cancers.
TGCTs are presumed to arise from a common precursor lesion,
carcinoma in situ (CIS), which is found within the seminiferous
tubules. TGCTs comprise two histologically distinct subtypes:
seminomas and non-seminomas. The seminoma subtype consists of
cells that resemble CIS but that are not constrained within the
seminiferoustubules.Thenon-seminomasubtyperepresentstumors
of mixed histology, including embryonal carcinoma, teratoma, and
polyembryoma, choriocarcinoma, or yolk sac tumor [3].
At present, the etiology of testicular cancer is not well
understood, but many risk factors—including cryptorchidism (a
condition in which one or both testes fail to descend normally);
inguinal hernia; contralateral testicular cancer; familial testicular
cancer; testicular trauma; mumps orchitis; elevated testicular
temperature; vasectomy; electromagnetic fields (EMF); and
hormonal, prenatal, and occupational factors—have been impli-
cated in this cancer’s development in young adults [4]. The nature
of these factors suggests that both genetic and environmental
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Until now, the most established factor associated with testicular
cancer is cryptorchidism, which is associated with a 2- to 4-fold
increase in the risk of testicular cancer but accounts for fewer than
10% of all cases [5].
Over the last 20–40 years, reports in the literature indicate a
decrease in the quality of sperm and an increase in the frequency
of testicular malignancies (especially seminoma) [6–8]. As many as
10 to 15% of all couples in western countries experience
subfertility (the condition of being less than normally fertile
though still capable of effecting fertilization), and in one third of
these cases, the problem can be attributed to the male partner [6–
8]. An association between the world-wide decrease in male
fertility and testicular cancer has been suggested [9–17], although
evidence for this type of association has been inconsistent [18–21],
and the exact etiology of such an association remains debatable.
The potential association between subfertility and the testicular
cancer has evoked a huge interest from clinicians, scientists, and
the public [22]. Thus, to elucidate and to provide a quantitative
assessment of the association between male subfertility and
testicular cancer, we performed a systematic review of studies
that evaluated such an association and our results indicated that
male subfertility is significantly related to an increased risk for
testicular cancer.
Methods
Search strategy
We conducted a literature search of the Medline database
(records from January 1,1966,throughMarch31,2008)using three
searchterms,whichwerecombined bythe Booleanoperator‘‘and.’’
The first theme was (‘‘Testicular Neoplasms’’[Mesh] OR ‘‘testicular
cancer’’ OR ‘‘testicular tumour’’), the second theme was (‘‘In-
fertility’’[Mesh] OR ‘‘Infertility, Male’’[Mesh] OR ‘‘subfertility’’),
and the third theme was (‘‘Case-Control Studies’’[Mesh] OR
‘‘case–control study’’ OR ‘‘Cohort Studies’’[Mesh] OR ‘‘cohort
study’’). We sought additional eligible studies by conducting a
manual search of reference lists from primary articles and relevant
reviews. We identified epidemiologic studies conducted in humans
from 1966 to 2008 that examined the association between
subfertility and testicular cancer incidence. Two readers indepen-
dently determined the eligibility of each article for inclusion in the
meta-analysis. Any disagreements during the selection process were
resolved by discussion with a third author.
Selection
Eligible studies: 1) described a male population with an
association between male subfertility and testicular cancer; 2)
described a case-control study or cohort study; 3) for a case-control
study, either provided an estimate of effect with odds ratio with
95% confidence interval (CI) or provided raw data from which
and odds ratio that could be calculated; for a cohort study,
provided an estimate of effect with rate ratio or standardized
incidence ratio with 95% CI; 4) included a study population where
the didagnosis of subfertility/fertility problem/infertility/low
fertility prior to diagnosis of testicular cancer; and 5) were written
in English.
Studies were excluded if no control group was included; if
subjects had a history of cryptorchidism; if the indicators of male
infertility, included offspring sex ratio, number of children,
offspring twin rates, and offspring sibship size.These indicators
are imperfect measures of male fertility, as they depend not the
combined reproductive capacity of both the male and female
partner. If duplicate publications from a single study were
found,then we included only the article that provided more
comprehensive information and was written in English.
Validity assessment
Case-control studies were evaluated for quality using the quality
assessment scale developed by Horwitz RI and colleagues [23],
which include12 methodologic standards. For each study,
compliance with each developed recommendation was rated
according to the following possible scores: positive (+), negative
(2), uncertain (6), and not applicable (NA) or not evaluable (NE).
For cohort studies, we recorded the following quality indicators:
approach to participant recruitment, length of follow-up, and
consideration of confounding factors.
Data abstraction
For each study, we abstracted the following data: 1) first
author’s name, year of publication, and country of the population
studied; 2) study design; 3) characteristics of the study subjects
(source of cases and controls, follow-up period for cohort studies);
4) number of exposed and unexposed subjects; 5) measures of
outcome and exposure; 6) variables for which statistical adjustment
was performed; 7) the relative risk (RR) or relative odds of
testicular cancer being associated with subfertility and its 95% CI;
and 8) history of cryptorchidism.
Quantitative data synthesis
RR was used as the measure of effect of interest. We used the
DerSimonian and Laird random-effects model to calculate a
pooled RR and its corresponding 95% CI for studies that reported
specific RRs [24,25]. RRs from individual studies were trans-
formed to their logarithms to stabilize the variances and to
normalize the distributions. To assess for heterogeneity of RRs
across studies, the Cochrane Q’s statistic and the I2 statistic were
calculated [26]. The variance of the log RRi ðÞ was derived from
the CI provided in the study [27].
Sensitivity analyses were performed by omitting one study at a
time and analyzing the remaining studies to detect whether the
results were influenced excessively by any single study. The
possibility of publication bias was assessed using visual inspection
of a funnel plot [28], and both the Begg and Egger tests were also
performed to assess the possibility of publication bias [29].
Furthermore, the Duval and Tweedie nonparametric trim-and-
fill procedure was performed to further assess the possible effect of
publication bias in our meta-analysis [30]. This method considers
the possibility of hypothetical ‘‘missing’’ studies that might exist,
imputes their RRs, and recalculates a pooled RR that incorporates
the hypothetical missing studies as though they actually existed.
Meta-analysis was performed using Microsoft Excel (Microsoft
Corp, Seattle, Washington), SPSS11.5 (SPSS Corp, Chicago,
Illinois), and Stata version 10.0 (Stata Corp, College Station,
Texas). P values less than 0.05 were considered statistically
significant, and all statistical tests were two-sided.
Results
Flow of included studies
From our review of abstracts, we initially selected 139 studies for
a more detailed review (References S1); we excluded 126 studies
because they were reviews, studies of other risk factors, or case
reports. From the remaining 13 studies, we excluded four because
the indicator to measure the male fertility problem was one of the
following: sex ratio, twin rates, and sibship size of offspring—or
because the population diagnosed with subfertility had a history of
cryptorchidism (Table 1). After review, nine studies were included
Risk of Testicular Cancer
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studies—four from the United States and three from Europe; two
of the nine were cohort studies—one from the United States and
one from Europe (Fig. 1).
Study characteristics
The characteristics of the included studies are listed in Table 2
(for case-control studies) and Table 3 (for cohort studies). The nine
studies that we included in the meta-analysis were published
between 1987 and 2005. The studies about subfertility were
registries or interviews and questionnaires. Seven case-control
studies used odds ratios and the 95% CIs as the measure of RR
[9–12,18–20] and enrolled a total of 4,954 participants. The total
subfertility case number was 2,099 (range of case subjects: 140 to
514), and the total number of control subjects was 2,855 (range of
control subjects: 135 to 720). Case subjects were all identified in
the cancer registry, with three hospital-based control subjects
[12,18,20] and four population-based control subjects [9–11,19].
Two cohort studies used standardized incidence ratios and the
95% CIs as the measure of RR [13,14] and had enrolled a total of
36,289 participants, with a mean follow-up period ranging from 6
to 20 years. Five studies were conducted in the United States (four
case-control studies and one cohort study) and four in Europe
(three case-control studies and one cohort study).
Quality assessment
The quality assessment score for the included seven case-control
studies is presented in Table 4. The criteria ‘‘Predetermined
method of selection’’, ‘‘Specification of the causal agent’’,
‘‘Avoidance of constrained cases’’, and ‘‘Avoidance of constrained
controls’’ were scored as positive in all studies. ‘‘Unbiased data
collection’’ was scored as positive in one study [12], negative in
Figure 1. QUOROM flow diagram (flow of included studies).
doi:10.1371/journal.pone.0005591.g001
Table 1. Reasons for four studies excluded from the meta-analysis.
First author Year (Ref. No.) Region Design Reasons for Exclusion
Richiardi L 2004 (15) Europe Cohort Included participants with a history of cryptorchidism; used
offspring twinning rates to define infertility
Fossa SD 2000 (16) Europe Cohort Used number of children to define infertility
Jacobsen R 2000 (17) Europe Cohort Used offspring sex-ratio to define infertility
Henderson BE 1979 (21) USA Case-control Used offspring sibship size to define infertility
doi:10.1371/journal.pone.0005591.t001
Risk of Testicular Cancer
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equivalence’’ was scored as positive in two studies [9,12], and
‘‘Equal demographic susceptibility’’ was scored as positive in six
studies and uncertain in one study [9,19]. ‘‘Equal clinical
susceptibility’’ was scored as positive in five studies and NA/NE
in two studies [9,19]. ‘‘Avoidance of Berkson’s bias’’ was scored as
positive in four studies [9,19] and negative in three studies [9,19].
‘‘Equal diagnostic examination’’ was scored as positive in two
studies [9,19] and NA/NE in five studies. Table 5 presents
corresponding quality criteria for the two cohort studies that were
included in our review, and these two studies met many of the
measured quality criteria [9,19].
Quantitative data synthesis
Individual study results and the overall summary results for the
seven case-controlled studies on the association between subfer-
tility and testicular cancer incidence are shown in Table 6. By
pooling the results of these seven studies [9–12,18–20], we found
that subfertility was associated with an increased risk of testicular
cancer (summary RR=1.68, 95% CI: 1.22 to 2.31)(Fig. 2). In a
sensitivity analysis in which one study at a time was excluded and
the rest were analyzed, we detected a statistically significant
positive association between subfertility and testicular cancer
incidence (range of summary RRs=1.56 to 1.92 and all the lower
limit of the 95% CIs.1.0).We then conducted subgroup meta-
Table 2. Characteristics of seven case-control studies of subfertility and testicular cancer incidence.
First Author
Year
(Ref. No.) Country
Excluded
Cryptorchidism
No. of Cases (Source of Cases)/No.
of Controls (Selection Method)
Estimated Odds
Ratios (95% CI)
Controlled
Variables
Baker JA 2005 (9) USA NA* 201 (Cancer registry)/204 (Population
controls matched by age and area of
residence)
9.47 (1.19–75.2) Age, neighborhood
Møller H 1999 (10) Europe (Danish) Yes 514 (Cancer registry)/720 (Population
controls matched by age)
1.42 (1.09–1.85) Age
Doria-Rose VP 2005 (11) USA Yes 329 (Cancer registry)/672 (Population
controls matched by age, race,
language and area of residence)
2.51 (1.07–5.86) Age
Swerdlow AJ 1989 (12) Europe (England) Yes 178 (Cancer registry)/315 (Hospital
patients matched by treatment center,
area of residence and duration of
follow-up)
1.73 (1.09–2.74) Area of hospital
Forman D PM 1994 (18) Europe (England
and Wales)
Yes 775 (Cancer registry)/794 (Hospital
patients matched by age, register
hospital or center, enrollment date
and area of residence)
2.66 (0.94–7.54) Age, area of
residence, and
register-time
Haughey BP 1989 (19) USA Yes 250 (Cancer registry)/250 (Population
controls matched by age and
neighborhood of residence)
4.77 (0.40–52.50) Age, neighborhood
Brown LM 1987 (20) USA NA 140 (Cancer registry)/135 (Hospital
patients without cancer matched by
treatment hospital, age, race, vital
status, year of diagnosis, and hospital
of diagnosis)
0.89 (0.40–1.96) Age, race, vital status
and year of diagnosis
*NA, not available. CI, confidence interval.
doi:10.1371/journal.pone.0005591.t002
Table 3. Characteristics of two cohort studies of subfertility and testicular cancer incidence.
First author
Year
(Ref. No) Country
Excluded
Cryptorchidism Study Population
Follow-up
Period
Estimated
Standardized
Incidence Ratios
(95% CI)
Controlled
Variables
Jacobsen R 2000 (13) Europe (Danish) NA* Exposed group: 32,442
subjects with a semen
analysis (No. of cases: 89)
1963–1995 1.60 (1.30–1.90) Age
Comparison group:
Danish population
Raman JD 2005 (14) USA Yes Exposed group: 3,847
subjects with abnormal
semen analysis (No. of
cases: 8)
1990–2000 18.30 (18.00–18.80) Age, race
Comparison group:
American population
*NA, not available.
doi:10.1371/journal.pone.0005591.t003
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possible presence of cryptorchidism. Analysis of four studies that
included population-based control subjects showed a positive
association (summary RR=2.15, 95% CI=1.11 to 4.17). Analysis
of three studies with hospital-based subjects [12,18,20], did not
support an association between subfertility and higher incidence of
testicular cancer (summary RR=1.56, 95% CI=0.93 to 2.61).
We found that a positive association between subfertility and
testicular cancer by region (the United States and Europe), with a
somewhat stronger association in the United States [9,11,19–20]
(summary RR=1.75, 95% CI=1.01 to 3.02) than in Europe
[10,12,18] (summary RR=1.53, 95% CI=1.22 to 1.92).
As a strong risk factor for both testicular cancer and subfertility,
cryptorchidism is a potentially important confounder of the
Table 4. Compliance with the 12 methodologic criteria in seven case-control studies.
First Author Baker JA Møller H Doria-Rose VP Swerdlow AJ Forman D PM Haughey BP Brown LM
Year (Ref. No.) 2005 (9) 1999 (10) 2005 (11) 1989 (12) 1994 (18) 1989 (19) 1987 (20)
Predetermined method +++ + + ++
Specification of the agent +++ + + ++
Unbiased data collection 6 2 6 + 66 g
Anamnestic eauivalence + g 6 + 66 6
Avoidance of constrained cases +++ + + ++
Avoidance of constrained controls +++ + + ++
Equal diagnostic examination ggg + gg +
Equal diagnostic surveillance ggg g g gg
Equal demographic susceptibility +++ 6 ++ +
Equal clinical susceptibility g ++ + + +g
Avoidance of protopathic bias ggg g g gg
Community control for Berkson’s bias +++ 22 + 2
+, positive; 2, negative; 6, uncertain; g, not applicable or not evaluable.
doi:10.1371/journal.pone.0005591.t004
Table 5. Quality indicators for cohort studies.
First author
Year
(Ref. No)
Same mode of
inclusion for
intervention
and control
group
Enough
F/U
duration
Report
of loss
of F/U
Adjusted
analysis for
confounding
variables
Mode of
participants
selection
described
Potential
important
baseline
differences
Sample size
prespecified
Report of
important
baseline
characteristics
modification
during F/U
Jacobsen R 2000 (13) Yes Yes No Yes Yes No Yes No
Raman JD 2005 (14) Yes Yes No Yes Yes Yes Yes Yes
doi:10.1371/journal.pone.0005591.t005
Table 6. Summary relative risk (RR) estimates and 95% confidence intervals (CIs) for seven case-control studies of the association
between subfertility and testicular cancer incidence.
Subgroup Studies (No.) Summary RR (95% CI) Between Studies
Q P Heterogeneity I
2 Statistics
Case-control studies 7 1.68 (1.22 to 2.3) 8.46 0.21 0.29
Population-based 4 2.15 (1.11 to 4.17) 5.36 0.15 0.44
Hospital-based 3 1.56 (0.93 to 2.61) 3.09 0.21 0.35
Region 0.20* 0.66
United States 4 1.75 (1.01 to 3.02) 6.61 0.09 0.55
Europe 3 1.53 (1.22 to 1.92) 1.66 0.44 0.20
Excluded cryptorchidism 5 1.59 (1.28 to 1.98) 3.63 0.46 0.10
*for between subgroup.
doi:10.1371/journal.pone.0005591.t006
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analyzed five studies [10–12,18–19] that excluded participants
with a history of cryptorchidism, and found a positive association
between subfertility and testicular cancer (summary RR=1.59,
95% CI=1.28 to 1.98).
Both cohort studies identified (one conducted in the United
States and the other in Europe) [13,14] reported a standardized
incidence ratios and a statistically significant positive association
between subfertility and testicular cancer (United States popula-
tion RR=18.3, 95% CI=18.0 to 18.8; Danish population
RR=1.6, 95% CI=1.3 to 1.9).
Publication bias
The funnel plot appears asymmetric (Fig. 3A), suggesting
publication bias—although the Begg test and Egger test were not
statistically significant (P=0.23 and 0.11, respectively). Therefore,
we performed a sensitivity analysis by using the trim-and-fill
method [30], which conservatively imputes hypothetical negative
unpublished studies to mirror the positive studies that cause funnel
plot asymmetry. The imputed studies produce a symmetrical
funnel plot (Figure 3B). The pooled analysis incorporating the
hypothetical studies continued to show a statistically significant
association between testicular cancer and subfertility (with
adjusted RR=1.51, 95% CI: 1.08–2.12; P,0.017).
Discussion
Discrepancies among previous studies investigating the rela-
tionship of subfertility with testicular cancer risk may be
attributable to small sample sizes that resulted in insufficient
statistical power to detect some relationships in the individual
studies. To address this uncertainty, we used rigorous meta-
analytic techniques to quantitatively assess the association more
precisely. The results of our meta-analysis support the association
of subfertility with subsequent risk for testicular cancer.
By pooling data from seven case-control studies meeting our
inclusion criteria, we demonstrated that individuals with subfer-
tility have an overall increased RR of developing testicular cancer
compared with control individuals; the results suggested a
consistent positive association between subfertility and testicular
cancer for studies carried out in the United States and in Europe,
for studies of population-based and hospital-based control subjects,
and for studies that completely excluded cryptorchidism. Two
cohort studies could not be made into a pooled analysis because
standardized incidence ratios were used as the measure of effect of
interest; however, both studies reported a statistically significant
positive association between subfertility and testicular cancer, with
a 1.6-and an 18.3-fold increased risk of testicular cancer among
subfertility patients, respectively.
Like all meta-analyses, this study had some limitations. First, the
definition of subfertility in this systematic review is a somewhat
comprehensive definition, and we included the studies that
reported on men who had been diagnosed with subfertility/
fertility problem/infertility/low fertility due to difficulty getting a
partner pregnant or to a sperm problem prior to a diagnosis of
testicular cancer. Second, the quality of case-control individual
studies was inconsistent as is shown in Table 4, with a lack of
unbiased data collection, anamnestic equivalence, equal diagnostic
Figure 2. Association between subfertility and testicular cancer incidence in the seven case-control studies.
doi:10.1371/journal.pone.0005591.g002
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control’’ for Berkson’s bias for some studies. Third, we only found
two cohort studies that reported standardized incidence ratios and
satisfied our inclusion criteria, and the data from these two cohort
studies could not be pooled with data from case-control studies. In
addition, we only found five studies that reported no history of
cryptorchidism and restricted our search strategy to include
articles in English only.
The results we obtained from the funnel plot analysis were
consistent with publication bias, that is, the presence of
unpublished negative studies. Because of this, we undertook a
sensitivity analysis using the trim-and-fill method. The trim-and-
fill sensitivity analysis did not change direction of the results,
although the strength of the association was somewhat weakened,
indicating that the association is not an artifact of unpublished
negative studies. Nevertheless, that possibility is not fully excluded
by this method. Therefore, further studies are needed to
supplement the results of this meta-analysis.
A relationship between subfertility and increased risk of
testicular cancer is epidemiologically plausible. First, it has been
suggested that during the past four decades human sperm counts
have declined and the incidence of testicular cancer has increased
[31–33]. Second, the incidence rate of testicular cancer in infertile
men (,0.5–1%) is much higher than that of the general
population (0.001%,0.01%), and men who present with subfer-
tility are of a similar age as men with the highest prevalence of
testicular cancer [14,34,35]. Third, after excluding the common
risk factors for testicular cancer and subfertility, such as the history
of cryptorchidism and chromosomal aberrations, men with
infertility also have an increased risk of developing testicular
cancer [11,14,22].
A relationship between subfertility and increased risk of
testicular cancer is biologically plausible. First, fetal and neonatal
life are important in the development of reproductive disorders,
and some studies have shown that in utero exposure to excess
environmental estrogens (EES) is a risk factor for subfertility and
testicular cancer [15,36–38]. Though the mechanism that
mediates these effects is not well understood, some investigators
propose that EES not only interferes in the normal testis endocrine
directly but also disrupts the hypothalamic-pituitary-testis axis,
resulting in abnormal function of sertoli cells; this disruption
impairs germ cell differentiation and the germ cells are
subsequently transformed to develop into carcinoma in situ
(CIS) [4,39]. Estimates predict that CIS will develop into testicular
cancer within 5 years of diagnosis in half of all cases, and all
patients who harbor CIS cells at puberty will eventually develop
testicular cancer [4].
Second, genetic defects provide robust evidence in favor of a
relationship between subfertility and increased risk of testicular
cancer. Brothers of men with testicular cancer have lower fertility
and a higher risk of having testicular cancer than age matched
controls [16]. The ‘‘gr/gr’’ (carries a number of genes specifically
involved in male germ cell development) deletion in the Y
chromosome has been found to be associated with subfertility and
TGCT [40]. Youngren et al. found that the Ter mutation in the
dead end gene (Dnd1) causes primordial germ cell (PGCs) loss and
TGCTs, and loss of PGCs precedes development of embryonal
carcinoma cells in 129-Ter/Ter mouse embryos [41]. Therefore,
inactivation of Dnd1 expression is implicated as the causal event
that drives PGCs to exit the germ line and transform to embryonal
carcinoma cells and TGCTs in 129-Ter/Ter mice [41].
Our findings provide evidence for a role of subfertility in
carcinogenesis of testicular cancer. Our study numbers were
limited and all of the involved studies were conducted in the
United States and Europ. In addition, selection and recall
biases may affect the association between male subfertility and
the subsequent development of testicular cancer. More and
larger case control studies or prospective studies with multi-
regional and multi-institutional cohorts of men presenting for
subfertility or infertility care are needed for a clearer
determination of the association of subfertility with increased
risk of testicular cancer.
Testicular cancer has a complex etiology; environmental factors
and genetic mutations both contribute to the increased risk of
developing testicular cancer. Therefore, future studies will take up
the exciting challenge to elucidate the mechanism of the
interaction between environmental factors and genetic mutations
(such as how the estrogen regulates the related gene of germ cell
development) that influences the spermatogenesis and carcino-
genesis of germ cells.
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Figure 3. Funnel plots with and without trim and fill.
doi:10.1371/journal.pone.0005591.g003
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